InvestSMART
  1. Home
  2. Research & Advice
  3. Research Tools
  4. Shares
  5. VanEck Global Healthcare Leaders ETF (HLTH)
  6. Company Announcements

VanEck Global Healthcare Leaders ETF (ASX: HLTH) - Announcements

Current share price for HLTH : $11.230 0.06 (0.53%)+

VanEck Global Healthcare Leaders ETF (HLTH) is an Exchange Traded Fund - commonly known as an ETF. For more details about how ETFs work, feel free to check out our What is an ETF? overview. VanEck Global Healthcare Leaders ETF (HLTH) gives investors exposure to a diversified portfolio of the largest international companies from the global healthcare sector. HLTH aims to provide investment returns before fees and other costs which track the performance of the Index.

Latest company announcements for VanEck Global Healthcare Leaders ETF (HLTH)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$52 Issued Units Outstanding as at 31 July 2023 1 Aug 2023 1:50PM $10.330 $11.230 risen by 8.71%
$52 Dividend component details 17 Jul 2023 8:24AM $9.910 $11.230 risen by 13.32%
$52 Dividend Reinvestment Plan Prices 3 Jul 2023 5:15PM $10.160 $11.230 risen by 10.53%
$52 Issued Units Outstanding as at 30 June 2023 3 Jul 2023 5:15PM $10.160 $11.230 risen by 10.53%
$52 Final Dividend/Distribution for period ending 30 June 2023 30 Jun 2023 8:20AM $10.250 $11.230 risen by 9.56%
$52 Dividend timetable 22 Jun 2023 8:34AM $10.210 $11.230 risen by 9.99%
$52 Issued Units Outstanding as at 31 May 2023 1 Jun 2023 3:23PM $10.370 $11.230 risen by 8.29%
$52 Issued Units Outstanding as at 30 April 2023 1 May 2023 3:41PM $10.790 $11.230 risen by 4.08%
$52 Issued Units Outstanding as at 31 March 2023 4 Apr 2023 9:55AM $10.560 $11.230 risen by 6.34%
$52 Half-Year Financial Report 13 Mar 2023 9:09AM $10.290 $11.230 risen by 9.14%
$52 Issued Units Outstanding as at 28 Feb 2023 2 Mar 2023 1:21PM $10.150 $11.230 risen by 10.64%
$52 Number of Outstanding Units as at 31 January 2023 1 Feb 2023 3:36PM $10.230 $11.230 risen by 9.78%
$52 Indicative dividends calendar for 2023 11 Jan 2023 9:25AM $10.380 $11.230 risen by 8.19%
$52 Number of Outstanding Units as at 31 December 2022 3 Jan 2023 4:06PM $10.480 $11.230 risen by 7.16%
$52 Number of Outstanding Units as at 30 November 2022 1 Dec 2022 3:55PM $10.840 $11.230 risen by 3.60%
$52 Number of Outstanding Units as at 31 October 2022 1 Nov 2022 10:04AM $10.500 $11.230 risen by 6.95%
$52 Number of Outstanding Units as at 30 September 2022 4 Oct 2022 9:59AM $9.740 $11.230 risen by 15.30%
$52 Annual Report FYE 30 June 2022 27 Sep 2022 3:40PM $9.540 $11.230 risen by 17.71%
$52 Replacement Product Disclosure Statement 27 Sep 2022 9:59AM $9.500 $11.230 risen by 18.21%
$52 Number of Outstanding Units as at 31 August 2022 1 Sep 2022 2:38PM $9.850 $11.230 risen by 14.01%
$52 Number of Outstanding Units as at 31 July 2022 2 Aug 2022 2:15PM $10.530 $11.230 risen by 6.65%
$52 Dividend component details 14 Jul 2022 12:11PM $10.640 $11.230 risen by 5.55%
$52 Number of Outstanding Units as at 30 June 2022 1 Jul 2022 3:57PM $10.070 $11.230 risen by 11.52%
$52 Dividend Reinvestment Plan Prices 1 Jul 2022 3:54PM $10.070 $11.230 risen by 11.52%
$52 Final Dividend/Distribution for period ending 30 June 2022 30 Jun 2022 8:34AM $10.120 $11.230 risen by 10.97%

26 - 50 of 78 results

Page 2 of 4

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.